15 вынікі
REFERENCE TO SEQUENCE LISTING
The Sequence Listing submitted Mar. 1, 2017 as a text file named "21105_0028U3_Sequence_Listing.txt," created on Mar. 1, 2017, and having a size of 32,768 bytes is hereby incorporated by reference pursuant to 37 C.F.R. .sctn. 1.52(e)(5).
BACKGROUND OF THE INVENTION
1.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to the fields of treating or diagnosing pain, shock, and/or inflammatory conditions in a subject. More specifically, the present invention is related to the use of a pharmaceutical composition that
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to the fields of treating or diagnosing pain, shock, and/or inflammatory conditions in a subject. More specifically, the present invention is related to the use of a pharmaceutical composition that
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to compositions and methods for preventing or treating inflammatory bowel disease and particularly to the use of docosahexaenoic acid for preventing or treating feline inflammatory bowel disease.
2. Description of
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to compositions and methods for presenting or treating inflammatory bowel disease and particularly to the use of docosahexaenoic acid for preventing or treating feline inflammatory bowel disease.
2. Description of
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to the topical application of conjugated linoleic acid together with fatty acid esters of ascorbic acid for the treatment of acute and chronic skin damage. Therapies according to the invention are particularly efficacious
BACKGROUND OF THE INVENTION
The present invention relates generally to methods of treatment and products for treating disorders. More specifically, the present invention relates to methods and compositions for preventing, treating or providing relief from inflammation of the joints, osteoarthritis,
FIELD OF THE INVENTION
The present application relates to the field of dietary supplement and to formulations for total enteral or parenteral nutrition and the prevention of fatty acid deficiency.
BACKGROUND OF THE INVENTION
Linoleic acid and alpha-linolenic acid are two fatty acids that cannot be
FIELD OF THE INVENTION
The present application relates to the field of dietary supplement and to formulations for total enteral or parenteral nutrition and the prevention of fatty acid deficiency.
BACKGROUND OF THE INVENTION
Linoleic acid and alpha-linolenic acid are two fatty acids that cannot be
FIELD OF THE INVENTION
This invention relates to pharmaceutical preparations (which expression is herein intended to include veterinary preparations) for use in combating infective organisms afflicting the animal body (which expression is herein intended to include the human body).
This invention
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of PCT International Applications PCT/ZA01/00098, PCT/ZA01/00099, and PCT/ZA01/00100, all filed Jul. 19, 2001, and all designating the U.S.
FIELD OF THE INVENTION
This invention relates to pharmaceutical preparations
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention generally relates to the fields of treating a pain, shock, and/or inflammatory condition in a subject. More specifically, the present invention is related to the use of a pharmaceutical composition that comprises one or more
BACKGROUND OF THE INVENTION
Gamma-linolenic acid (GLA) is an essential fatty acid in the omega-6 family that is found primarily in plant-based oils. GLA is synthesized from linoleic acid (LA) via the action of the enzyme delta-six desaturase (.DELTA.6-desaturase). The beneficial effects of GLA
FIELD OF THE INVENTION
The present invention relates generally to the treatment of eye disorders, and, in particular, to an orally administered treatment for dry eye syndrome.
BACKGROUND OF THE INVENTION
Sufficient lubricating tears are critical to good eye health. Because tears provide the same
FIELD OF THE INVENTION
The invention relates in general, to a novel oil extracted from the seeds of Momordica charantia L., (bitter gourd), its preparation and use as anti-inflammatory, anti-arthritic, vasculodilatory and wound healing agent.
BACKGROUND
The invention relates to a novel oil extracted